Fuller & Thaler Asset Management’s Boston Scientific BSX Stock Holding History

Fuller & Thaler Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$475K	Hold	7,575	–	–	﹤0.01%	436
2025 Q4	$722K	Hold	7,575	–	–	﹤0.01%	410
2025 Q3	$740K	Hold	7,575	–	–	﹤0.01%	408
2025 Q2	$814K	Hold	7,575	–	–	﹤0.01%	405
2025 Q1	$764K	Hold	7,575	–	–	﹤0.01%	413
2024 Q4	$677K	Hold	7,575	–	–	﹤0.01%	434
2024 Q3	$635K	Hold	7,575	–	–	﹤0.01%	417
2024 Q2	$583K	Hold	7,575	–	–	﹤0.01%	455
2024 Q1	$519K	Hold	7,575	–	–	﹤0.01%	426
2023 Q4	$438K	Buy	7,575 +1,550	+26%	+$82.7K	﹤0.01%	422
2023 Q3	$318K	Buy	6,025 +300	+5%	+$15.7K	﹤0.01%	417
2023 Q2	$310K	Buy	5,725 +1,490	+35%	+$77.8K	﹤0.01%	424
2023 Q1	$212K	Hold	4,235	–	–	﹤0.01%	422
2022 Q4	$196K	Sell	4,235 -2,500	-37%	-$108K	﹤0.01%	411
2022 Q3	$261K	Sell	6,735 -2,325	-26%	-$93.3K	﹤0.01%	406
2022 Q2	$338K	Sell	9,060 -5,500	-38%	-$224K	﹤0.01%	419
2022 Q1	$645K	Sell	14,560 -4,800	-25%	-$208K	﹤0.01%	418
2021 Q4	$822K	Sell	19,360 -2,800	-13%	-$118K	﹤0.01%	406
2021 Q3	$962K	Sell	22,160 -1,500	-6%	-$66.4K	0.01%	392
2021 Q2	$1.01M	Sell	23,660 -4,000	-14%	-$168K	0.01%	390
2021 Q1	$1.07M	Sell	27,660 -5,200	-16%	-$197K	0.01%	369
2020 Q4	$1.18M	Buy	32,860 +60	+0.2%	+$2.16K	0.01%	349
2020 Q3	$1.25M	Hold	32,800	–	–	0.02%	335
2020 Q2	$1.15M	Hold	32,800	–	–	0.02%	323
2020 Q1	$1.07M	Sell	32,800 -38,450	-54%	-$1.5M	0.02%	309
2019 Q4	$3.22M	Buy	71,250 +13,530	+23%	+$566K	0.04%	252
2019 Q3	$2.35M	Hold	57,720	–	–	0.03%	267
2019 Q2	$2.48M	Sell	57,720 -8,825	-13%	-$339K	0.03%	265
2019 Q1	$2.55M	Sell	66,545 -15,610	-19%	-$596K	0.03%	249
2018 Q4	$2.9M	Sell	82,155 -22,685	-22%	-$823K	0.04%	233
2018 Q3	$4.04M	Sell	104,840 -52,205	-33%	-$1.82M	0.04%	241
2018 Q2	$5.13M	Hold	157,045	–	–	0.06%	209
2018 Q1	$4.29M	Buy	157,045 +50	+0%	+$1.36K	0.05%	217
2017 Q4	$3.89M	Sell	156,995 -65,705	-30%	-$1.81M	0.05%	194
2017 Q3	$6.5M	Sell	222,700 -8,900	-4%	-$246K	0.08%	146
2017 Q2	$6.42M	Sell	231,600 -19,300	-8%	-$512K	0.08%	140
2017 Q1	$6.24M	Buy	250,900 +48,000	+24%	+$1.17M	0.09%	142
2016 Q4	$4.39M	Buy	202,900 +28,900	+17%	+$631K	0.07%	153
2016 Q3	$4.14M	Buy	174,000 +31,800	+22%	+$759K	0.07%	151
2016 Q2	$3.32M	Buy	+142,200	New	+$3.08M	0.06%	157
2014 Q3	–	Sell	-8,700	Closed	-$111K	–	652
2014 Q2	$111K	Hold	8,700	–	–	﹤0.01%	580
2014 Q1	$118K	Sell	8,700 -3,100	-26%	-$40.7K	0.01%	574
2013 Q4	$142K	Sell	11,800 -22,000	-65%	-$260K	0.01%	456
2013 Q3	$397K	Buy	33,800 +21,500	+175%	+$233K	0.02%	310
2013 Q2	$114K	Buy	+12,300	New	+$104K	0.01%	450

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fuller & Thaler Asset Management's BSX Position: Q1 2026 in Review

Fuller & Thaler Asset Management held its Boston Scientific (BSX) position steady in Q1 2026 at 7,575 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #436.

Fuller & Thaler Asset Management first reported a position in BSX in Q2 2013 and has held it in 45 quarters since. The position peaked at $6.5M in Q3 2017. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Fuller & Thaler Asset Management held 7,575 shares of Boston Scientific worth $475K as of Q1 2026.
Fuller & Thaler Asset Management left its Boston Scientific share count unchanged in Q1 2026.
Boston Scientific made up ﹤0.01% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #436 holding.
Fuller & Thaler Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 45 quarters since.
Fuller & Thaler Asset Management's Boston Scientific position peaked at $6.5M in Q3 2017.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.